N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.226 NOK 2.68% Market Closed
Market Cap: 726.9m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Nykode Therapeutics ASA

Current Assets 140m
Cash & Short-Term Investments 136.5m
Receivables 3.5m
Non-Current Assets 39.9m
PP&E 9.3m
Intangibles 72k
Other Non-Current Assets 30.5m
Current Liabilities 15.1m
Accounts Payable 3.4m
Other Current Liabilities 11.7m
Non-Current Liabilities 12.7m
Long-Term Debt 3.4m
Other Non-Current Liabilities 9.3m

Balance Sheet
Nykode Therapeutics ASA

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
4
3
10
183
216
206
162
Cash
0
4
3
10
183
216
206
162
Cash Equivalents
2
0
0
0
0
0
0
0
Short-Term Investments
0
16
11
22
25
12
0
0
Total Receivables
22
1
1
1
20
26
4
1
Accounts Receivables
0
0
0
0
19
24
3
0
Other Receivables
0
1
0
1
1
2
2
1
Other Current Assets
0
0
0
0
1
2
2
3
Total Current Assets
25
21
15
33
229
256
212
166
PP&E Net
0
0
0
0
0
9
10
11
PP&E Gross
0
0
0
0
0
9
10
11
Accumulated Depreciation
0
0
0
0
0
1
3
5
Intangible Assets
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
1
0
0
32
Other Long-Term Assets
0
0
0
0
0
0
0
0
Total Assets
25
N/A
21
-15%
15
-29%
33
+120%
230
+589%
266
+15%
221
-17%
208
-6%
Liabilities
Accounts Payable
0
1
1
2
2
3
2
1
Accrued Liabilities
0
0
0
1
6
4
5
4
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
1
1
1
Other Current Liabilities
1
0
1
2
5
23
30
14
Total Current Liabilities
2
1
1
4
13
31
39
21
Long-Term Debt
0
0
0
0
0
6
4
4
Deferred Income Tax
0
0
0
0
31
29
21
12
Other Liabilities
0
0
0
1
7
5
0
0
Total Liabilities
2
N/A
1
-38%
1
+21%
6
+339%
51
+789%
72
+40%
64
-10%
37
-43%
Equity
Common Stock
21
0
0
0
0
0
0
0
Retained Earnings
5
9
15
31
121
115
76
45
Additional Paid In Capital
8
28
28
59
60
82
83
129
Other Equity
0
0
0
1
3
3
3
3
Total Equity
23
N/A
20
-13%
14
-31%
28
+99%
179
+547%
194
+9%
157
-19%
171
+9%
Total Liabilities & Equity
25
N/A
21
-15%
15
-29%
33
+120%
230
+589%
266
+15%
221
-17%
208
-6%
Shares Outstanding
Common Shares Outstanding
56
56
56
55
285
290
295
327

See Also

Discover More